Sage Therapeutics Inc. sell StockNews.com
Start price
07.06.25
/
50%
€5.93
Target price
07.06.26
-
Performance (%)
27.78%
End price
08.06.26
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 27.78%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sage Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by StockNews_com for this prediction
In the thread Sage Therapeutics Inc. diskutieren
Sage Therapeutics, Inc. (NASDAQ: SAGE) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for SAGE provided by MarketBeat
In the thread Trading Sage Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.32
20.04.24
20.04.24
-
20.04.25
20.04.25
-46.75%
21.04.25
21.04.25
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€18.10
20.08.23
20.08.23
-
20.08.24
20.08.24
-58.06%
21.08.24
21.08.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€20.40
12.08.23
12.08.23
-
12.08.24
12.08.24
-63.58%
13.08.24
13.08.24